Two different dosages of nebulized steroid versus parenteral steroid in the management of COPD exacerbations: A randomized control trial

Ucar E. Y., ARAZ Ö., MERAL M., SONKAYA E., SAĞLAM L., KAYNAR H., ...Daha Fazla

MEDICAL SCIENCE MONITOR, cilt.20, ss.513-520, 2014 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20
  • Basım Tarihi: 2014
  • Doi Numarası: 10.12659/msm.890210
  • Dergi Adı: MEDICAL SCIENCE MONITOR
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.513-520
  • Anahtar Kelimeler: Budesonide, therapeutic use, Methylprednisolone, therapeutic use, Pulmonary Disease, Chronic Obstructive, drug therapy, OBSTRUCTIVE PULMONARY-DISEASE, ORAL PREDNISOLONE, INHALED FLUTICASONE, LUNG-FUNCTION, BUDESONIDE, ASTHMA, CORTICOSTEROIDS, COMPLICATIONS, DECLINE
  • Atatürk Üniversitesi Adresli: Evet

Özet

Background: The study aimed to compare the efficacy and safety of nebulized steroid (NS) with systemic corticosteroids (SC) and to determine optimal NS dose in the treatment of patients with COPD exacerbations requiring hospitalization.